Intracellular and in vivo activities of oxazolidinone drugs against Mycobacterium avium complex infection

The prevalence of Mycobacterium avium complex-pulmonary disease (MAC-PD) has become a growing concern worldwide, and current treatments involving macrolides (clarithromycin [CLR] or azithromycin), ethambutol, and rifampicin have limited success, highlighting the need for better therapeutic strategie...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Ju Mi, Kim, Lee-Han, Kim, Su-Young, Jhun, Byung Woo, Lee, Wonsik, Shin, Sung Jae
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10667338/
https://www.ncbi.nlm.nih.gov/pubmed/37996500
http://dx.doi.org/10.1038/s41598-023-48001-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10667338/
https://www.ncbi.nlm.nih.gov/pubmed/37996500
http://dx.doi.org/10.1038/s41598-023-48001-y

Ejemplares similares